Phraxis Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $5.56M
Latest Deal Amount
  • Investors
  • 1

Phraxis General Information


Developer of medical devices designed to cure diseases. The company develops medical devices that helps patients who need vascular access to enable hemodialysis and it offers InterGraft, a percutaneously delivered arterio-venous shunt that provides a non-surgical approach for patients who need vascular access, enabling users to cure diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Other Devices and Supplies
Primary Office
  • 2910 13th Terrace Northwest
  • St. Paul
  • New Brighton, MN 55112
  • United States
+1 (651) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phraxis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 11-Mar-2019 $5.56M 00.00 Completed Startup
4. Undetermined 23-Oct-2013 00.000 00.000 Completed Startup
3. Angel (individual) 21-Dec-2012 00.00 00.00 Completed Startup
2. Convertible Debt 07-Feb-2012 $200K $800K Completed Startup
1. Convertible Debt 20-Dec-2010 $600K $600K Completed Startup
To view Phraxis’s complete valuation and funding history, request access »

Phraxis Patents

Phraxis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210069403-A1 One piece anastomotic connector Pending 08-Feb-2018 0000000000
US-20210068836-A1 End to end anastomotic connector Pending 08-Feb-2018 000000000
EP-3749225-A1 One piece anastomotic connector Pending 08-Feb-2018 0000000000
EP-3749224-A1 End to end anastomotic connector Pending 08-Feb-2018 000000000
US-10786346-B2 Arterial anchor devices forming an anastomotic connector Active 16-Aug-2012 A61F2/064

Phraxis Executive Team (5)

Name Title Board Seat Contact Info
James Hickey Jr. Board Member & Chief Executive Officer
Shelley Olsen Chief Financial Officer
Michael Kallok Ph.D Board Member & Chief Technology Officer
Alexander Yevzlin MD Co-Founder, Director & Chief Scientific Officer
John Seaberg Co-Founder & Chairman
To view Phraxis’s complete executive team members history, request access »

Phraxis Board Members (4)

Name Representing Role Since
James Hickey Jr. Phraxis Board Member & Chief Executive Officer 000 0000
John Seaberg Self Co-Founder & Chairman 000 0000
John Zentgraf Phraxis Board Member & Co-Founder 000 0000
Michael Kallok Ph.D Self Board Member & Chief Technology Officer 000 0000
To view Phraxis’s complete board members history, request access »

Phraxis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phraxis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kevin D'Silva Angel (individual) 000 0000 000000 0
To view Phraxis’s complete investors history, request access »